Paper16770646
CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis.
Vuilleumier N and 8 others. Eur J Clin Pharmacol, 2006. Cited by 119 papers, by iCite.
Cite this record
ConductScience Library. CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis. Papers, record 16770646. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16770646
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antitubercular Agents | Major topic |
| Cytochrome P-450 CYP2E1 | Major topic |
| Isoniazid | Major topic |
| Liver | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Arylamine N-Acetyltransferase | |
| Base Sequence | |
| Chemical and Drug Induced Liver Injury | |
| DNA Primers | |
| Female | |
| Gene Frequency | |
| Genotype | |
| Humans | |
| Male | |
| Middle Aged | |
| Pharmacogenetics | |
| Polymorphism, Restriction Fragment Length | |
| Prospective Studies | |
| Tuberculosis, Pulmonary |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9295061 | Arylamine N-acetyltransferase (NAT2) genotypes in a Turkish population. | Pharmacogenetics | 1997 | https://conductscience.org/library/papers/9295061 | PubMed |
| 2 | 2304098 | Isoniazid toxicity presenting as seizures and metabolic acidosis. | J Natl Med Assoc | 1990 | https://conductscience.org/library/papers/2304098 | PubMed |
| 3 | 12172891 | Cytochrome P4502E1 phenotyping by the measurement of the chlorzoxazone metabolic ratio: assessment of its usefulness in workers exposed to styrene. | Int Arch Occup Environ Health | 2002 | https://conductscience.org/library/papers/12172891 | PubMed |
| 4 | 3717759 | Rifampin-induced release of hydrazine from isoniazid. A possible cause of hepatitis during treatment of tuberculosis with regimens containing isoniazid and rifampin. | Am Rev Respir Dis | 1986 | https://conductscience.org/library/papers/3717759 | PubMed |
| 5 | 9321764 | A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid. | J Med Genet | 1997 | https://conductscience.org/library/papers/9321764 | PubMed |
| 6 | 11131457 | Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. | J Hepatol | 2000 | https://conductscience.org/library/papers/11131457 | PubMed |
| 7 | 7668286 | Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity. | Am J Hum Genet | 1995 | https://conductscience.org/library/papers/7668286 | PubMed |
| 8 | 7288121 | Risk factors for isoniazid (NIH)-induced liver dysfunction. | J Clin Gastroenterol | 1981 | https://conductscience.org/library/papers/7288121 | PubMed |
| 9 | 10881762 | Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. | MMWR Recomm Rep | 2000 | https://conductscience.org/library/papers/10881762 | PubMed |
| 10 | 10889908 | Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis. | Mol Pathol | 2000 | https://conductscience.org/library/papers/10889908 | PubMed |
| 11 | 8354023 | Inhibition and induction of cytochrome P4502E1-catalyzed oxidation by isoniazid in humans. | Clin Pharmacol Ther | 1993 | https://conductscience.org/library/papers/8354023 | PubMed |
| 12 | 10208651 | Pitfalls in N-acetyltransferase 2 genotyping. | Pharmacogenetics | 1999 | https://conductscience.org/library/papers/10208651 | PubMed |
| 13 | 10886461 | Cytochrome P450 2E1: its clinical and toxicological role. | J Clin Pharm Ther | 2000 | https://conductscience.org/library/papers/10886461 | PubMed |
| 14 | 9131488 | N-acetyltransferases: pharmacogenetics and clinical consequences of polymorphic drug metabolism. | J Pharmacokinet Biopharm | 1996 | https://conductscience.org/library/papers/9131488 | PubMed |
| 15 | 7485004 | Hepatotoxicity from isoniazid and rifampin in inner-city AIDS patients. | Am J Gastroenterol | 1995 | https://conductscience.org/library/papers/7485004 | PubMed |
| 16 | 666111 | Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study. | Am Rev Respir Dis | 1978 | https://conductscience.org/library/papers/666111 | PubMed |
| 17 | 3997827 | Characterization of a major form of rat hepatic microsomal cytochrome P-450 induced by isoniazid. | J Biol Chem | 1985 | https://conductscience.org/library/papers/3997827 | PubMed |
| 18 | 3957235 | Elevated serum aminotransferase induced by isoniazid in relation to isoniazid acetylator phenotype. | Hepatology | 1986 | https://conductscience.org/library/papers/3957235 | PubMed |
| 19 | 6367570 | Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberculosis. | Am Rev Respir Dis | 1984 | https://conductscience.org/library/papers/6367570 | PubMed |
| 20 | 10708202 | Acute isoniazid neurotoxicity during preventive therapy. | Crit Care Med | 2000 | https://conductscience.org/library/papers/10708202 | PubMed |
Cited by63
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41104340 | Pharmacogenomics of antibiotic-induced hypersensitivity reactions: current evidence and implications in clinical practice. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41104340 | PubMed |
| 40538374 | Genetic polymorphisms and adverse reactions to antituberculosis therapy. | Pharmacogenomics | 2025 | https://conductscience.org/library/papers/40538374 | PubMed |
| 40488658 | Drug metabolizing enzymes and transporters, and their roles for the development of drug-induced liver injury. | Expert Opin Drug Metab Toxicol | 2025 | https://conductscience.org/library/papers/40488658 | PubMed |
| 39959342 | Clinical perspectives of isoniazid-induced liver injury. | Liver Res | 2021 | https://conductscience.org/library/papers/39959342 | PubMed |
| 39639188 | Pharmacogenomic insights into tuberculosis treatment shows the NAT2 genetic variants linked to hepatotoxicity risk: a systematic review and meta-analysis. | BMC Genom Data | 2024 | https://conductscience.org/library/papers/39639188 | PubMed |
| 38702595 | Influencing risk factors of voriconazole-induced liver injury in Uygur pediatric patients undergoing allogeneic hematopoietic stem cell transplantation. | BMC Pediatr | 2024 | https://conductscience.org/library/papers/38702595 | PubMed |
| 38520539 | Formation of potentially toxic metabolites of drugs in reactions catalyzed by human drug-metabolizing enzymes. | Arch Toxicol | 2024 | https://conductscience.org/library/papers/38520539 | PubMed |
| 37786472 | Association of Cytochrome P450 2E1 and N-Acetyltransferase 2 Genotypes with Serum Isoniazid Level and Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Cross-Sectional Study. | Iran J Med Sci | 2023 | https://conductscience.org/library/papers/37786472 | PubMed |
| 37070117 | Hepatotoxicity induced by isoniazid in patients with latent tuberculosis infection: a meta-analysis. | Gastroenterol Hepatol Bed Bench | 2023 | https://conductscience.org/library/papers/37070117 | PubMed |
| 36562936 | Polymorphisms in drug metabolism genes as a risk factor for first-line anti-tuberculosis drug-induced liver injury. | Mol Biol Rep | 2023 | https://conductscience.org/library/papers/36562936 | PubMed |
| 36078027 | Hepatic, Extrahepatic and Extracellular Vesicle Cytochrome P450 2E1 in Alcohol and Acetaminophen-Mediated Adverse Interactions and Potential Treatment Options. | Cells | 2022 | https://conductscience.org/library/papers/36078027 | PubMed |
| 35751408 | NAT2 and CYP2E1 polymorphisms and antituberculosis drug-induced hepatotoxicity in Peruvian patients. | Mol Genet Genomic Med | 2022 | https://conductscience.org/library/papers/35751408 | PubMed |
| 34539416 | Herb-Induced Liver Injury Related to Reynoutria multiflora (Thunb.) Moldenke: Risk Factors, Molecular and Mechanistic Specifics. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34539416 | PubMed |
| 34510815 | Allelic and genotypic frequencies of NAT2, CYP2E1, and AADAC genes in a cohort of Peruvian tuberculosis patients. | Mol Genet Genomic Med | 2021 | https://conductscience.org/library/papers/34510815 | PubMed |
| 33981901 | CYP2E1, GSTM1, and GSTT1 genetic polymorphisms and their associations with susceptibility to antituberculosis drug-induced liver injury in Thai tuberculosis patients. | Heliyon | 2021 | https://conductscience.org/library/papers/33981901 | PubMed |
| 33649521 | Development of a population pharmacokinetic model and Bayesian estimators for isoniazid in Tunisian tuberculosis patients. | Pharmacogenomics J | 2021 | https://conductscience.org/library/papers/33649521 | PubMed |
| 31375612 | Association of genetic polymorphisms of CYP2E1, NAT2, GST and SLCO1B1 with the risk of anti-tuberculosis drug-induced liver injury: a systematic review and meta-analysis. | BMJ Open | 2019 | https://conductscience.org/library/papers/31375612 | PubMed |
| 30871660 | NAT2 variants and toxicity related to anti-tuberculosis agents: a systematic review and meta-analysis. | Int J Tuberc Lung Dis | 2019 | https://conductscience.org/library/papers/30871660 | PubMed |
| 30090405 | Induction of protective autophagy against apoptosis in HepG2 cells by isoniazid independent of the p38 signaling pathway. | Toxicol Res (Camb) | 2016 | https://conductscience.org/library/papers/30090405 | PubMed |
| 30047605 | The association between the NAT2 genetic polymorphisms and risk of DILI during anti-TB treatment: a systematic review and meta-analysis. | Br J Clin Pharmacol | 2018 | https://conductscience.org/library/papers/30047605 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CYP2E1 | 1571 | PubTator's text mining | https://conductscience.org/library/genes/1571 | NCBI Gene |
| NAT2 | 10 | PubTator's text mining | https://conductscience.org/library/genes/10 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16770646
GET https://conductscience.org/api/papers/v1/16770646/references?page=2